Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC

SIMPLE SUMMARY: Pancreatic cancer is one of the hardest-to-treat cancers. This is mainly due to its heterogeneity, where subsets of cancer cells possess distinct properties and abilities that determine if and how they metastasize or respond to therapy. DNA barcoding technologies have emerged as a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Dujardin, Philip, Baginska, Anna K., Urban, Sebastian, Grüner, Barbara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394487/
https://www.ncbi.nlm.nih.gov/pubmed/34439341
http://dx.doi.org/10.3390/cancers13164187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394487/
https://www.ncbi.nlm.nih.gov/pubmed/34439341
http://dx.doi.org/10.3390/cancers13164187

Ejemplares similares